Preferred Name

Mepolizumab
Synonyms
Definitions

A humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against interleukin-5 (IL-5) with anti-asthmatic and potential immunosuppressive activity. Upon subcutaneous administration, mepolizumab selectively binds to IL-5, preventing it from associating with interleukin-5 receptor subunit alpha (IL5RA) on the surface of eosinophils and their progenitors. IL-5 plays a role in the regulation of eosinophil development from hematopoietic progenitors as well as eosinophil maturation, differentiation, mobilization, activation, and survival. IL-5 also play a role in the pathogenesis of some phenotypes of hypereosinophilic syndrome (HES).

ID

http://purl.obolibrary.org/obo/NCIT_C157376

CAS_Registry

196078-29-2

code

C157376

Contributing_Source

CTRP

FDA

definition

A humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against interleukin-5 (IL-5) with anti-asthmatic and potential immunosuppressive activity. Upon subcutaneous administration, mepolizumab selectively binds to IL-5, preventing it from associating with interleukin-5 receptor subunit alpha (IL5RA) on the surface of eosinophils and their progenitors. IL-5 plays a role in the regulation of eosinophil development from hematopoietic progenitors as well as eosinophil maturation, differentiation, mobilization, activation, and survival. IL-5 also play a role in the pathogenesis of some phenotypes of hypereosinophilic syndrome (HES).

Display_Name

Mepolizumab

FDA_UNII_Code

90Z2UF0E52

Has_Target

http://purl.obolibrary.org/obo/NCIT_C26269

in_subset

http://purl.obolibrary.org/obo/NCIT_C63923

http://purl.obolibrary.org/obo/NCIT_C176424

http://purl.obolibrary.org/obo/NCIT_C116977

http://purl.obolibrary.org/obo/NCIT_C116978

label

Mepolizumab

NCI_Drug_Dictionary_ID

796922

NCI_META_CUI

CL936998

PDQ_Closed_Trial_Search_ID

796922

PDQ_Open_Trial_Search_ID

796922

Preferred_Name

Mepolizumab

prefixIRI

NCIT:C157376

prefLabel

Mepolizumab

Semantic_Type

Amino Acid, Peptide, or Protein

Pharmacologic Substance

subClassOf

http://purl.obolibrary.org/obo/NCIT_C20401

http://purl.obolibrary.org/obo/NCIT_C29712

Delete Subject Author Type Created
No notes to display